FPS
BVS icon

Fieldpoint Private Securities’s Bioventus BVS Stock Holding History

Fieldpoint Private Securities’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-83
Closed -$1K – 1664
2021
Q4 		$1K Buy
+83
New +$1.18K ﹤0.01% 1537

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Fieldpoint Private Securities's BVS Position: Q1 2022 in Review

Fieldpoint Private Securities sold out of Bioventus (BVS) in Q1 2022, closing a stake of 83 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in BVS in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 105 funds tracked by Wall St. Rank hold BVS as of Q1 2022.

  • Fieldpoint Private Securities reported no remaining Bioventus position as of Q1 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 83 Bioventus shares in Q1 2022, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Bioventus in Q4 2021 and held it in 1 quarter.
  • Fieldpoint Private Securities's Bioventus position peaked at $1K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Bioventus as of Q1 2022.

Based on Fieldpoint Private Securities's 13F filing for Q1 2022, filed 7 Apr 2022.